Jungle Juice: Knowledge and Usage Among Kenyan Surgical Teams
Abstract
Background: Lidocaine Adrenaline combination (LAC) in saline (jungle juice) is used to provide peri-operative analgesia, blood conservation and separation of tissue planes. It comprises 20mls of 2% Lidocaine, 80mls of sterile saline and 0.5mls of 1:1000 Adrenaline solution, +/- hyaluronidase. This survey aimed to evaluate knowledge and safe usage of jungle juice on patients in Kenyan public hospitals.
Objectives: To establish formulation, extent of usage, patterns and safety measures employed during use of jungle juice among surgical teams in Kenya. Methods: A cross sectional descriptive survey among 344 surgeons.and.66 anesthesiologists.
Results: Majority (95.2%) of the respondents could not constitute the recommended jungle juice solution. Most (66.3%) had learnt about jungle juice from medical school and workmates (28.9%). About half of the anesthesiologists and 13.6% of surgeons were aware of the maximum dose of lidocaine with adrenaline. Regarding the specific antidote for severe local anesthetic toxicity and its dosage, 3.2% of surgeons and 18.2% of anesthesiologists had good awareness. Intralipid Emulsion was available in operating theaters to 3.9% of surgeons and 18.2% of anesthesiologists.
Conclusions: Most of the Kenyan surgical teams had poor knowledge on the preparation and safe use of jungle juice.
Keywords: Lidocaine Adrenaline Combination, Jungle Juice, Intralipid Emulsion
Authors submitting articles to The Annals of African Surgery do so on the understanding that if accepted, they will retain the copyright and allow the journal to publish and archive the article under the CC BY (Creative Commons Attribution License) 4.0 International. See details on the Creative commons website. All authors will be required to sign an Author Agreement form detailing the agreement with the journal prior to the article being published. Download the form here
© 2019 Annals of African Surgery. This work is licensed under the Creative Commons Attribution 4.0 International License.
